Dr Mona Shahriari Discusses Treatment of Plaque Psoriasis in Patients With Skin of Color
October 26th 2023Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University and associate director of clinical trials at Central Connecticut Dermatology, provides on overview of the treatment landscape in patients with skin of color with plaque psoriasis.
Read More
Allina Health’s Mike Koroscik on Revolutionizing Early Cancer Detection Through Technology
October 26th 2023Through the integration of a population health reimbursement model in 2020, Allina Health Cancer Institute was able to implement expanded screening initiatives through the use of artificial intelligence and precision medicine, according to Mike Koroscik, MBA, MHA, vice president of oncology, Allina Health.
Read More
Racial, Ethnic Disparities Seen in Breast Cancer Survival, Even Among Clinical Trial Participants
October 25th 2023It is critical to understand the role race and ethnicity play in survival for patients with early-stage breast cancer (eBC), as well as explore potential interventions to close these gaps.
Read More
Burnout Decreases Quality of Life in Both Patients and Clinicians in Reproductive Health Fields
October 20th 2023Posters presented at the American Society for Reproductive Medicine (ASRM) 2023 Scientific Congress & Expo addressed psychosocial symptoms and burdens faced by both embryologists and women of color with uterine fibroids.
Read More
Dr Brian Mullen Shares Digital Health Advancements at The Clinic by Cleveland Clinic
October 19th 2023Brian Mullen, PhD, head of innovation and product at The Clinic by Cleveland Clinic, discusses the implementation of digital health tools and strategies made by The Clinic and what these improvements mean for its patients.
Read More
Dr Anita Allen Discusses the Current Regulatory Landscape on Abortions
October 19th 2023Anita Allen, PhD, professor of law and philosophy, University of Pennsylvania, discusses the impact of abortion regulations in different parts of the world on women's reproductive access and rights, as well as the repercussions of the Dobbs decision that overturned Roe v Wade.
Read More
Dr Joseph Chervenak Discusses How Large Language Models Are Revolutionizing Reproductive Care
October 17th 2023Joseph Chervenak, MD, MBA, obstetrician and gynecologist, Montefiore Institute for Reproductive Medicine and Health, breaks down the benefits and challenges associated with implementing large language models such as ChatGPT into reproductive medicine and fertility care.
Read More
Patient, Provider Education and Payer Management Can Improve Biosimilar Uptake: Dr Bincy Abraham
October 15th 2023Biosimilars are becoming more common as more launch on the market in the United States, but patient and provider education can help speed uptake of these products, explained Bincy Abraham, MD, Houston Methodist – Weill Cornell.
Read More
Dr David Adamson Discusses How Professional Guidelines Impact Reproductive Care Outcomes
October 13th 2023David Adamson, MD, FRCSC, FACOG, FACS, reproductive endocrinologist, surgeon, founder and CEO of ARC Fertility, and past president of The American Society for Reproductive Medicine, discusses the importance of professional guidelines in reproductive medicine.
Read More
Ruben A. Mesa, MD, FACP, president and executive director of Atrium Health Levine Cancer Institute (LCI) and Atrium Health Wake Forest Baptist Comprehensive Cancer Center, discusses how practices can improve access and affordability to treatments for rare cancers, such as myeloproliferative neoplasms.
Read More
Dr Steven Deitelzweig: Identifying Patients With Atrial Fibrillation Using a Detection Device
October 10th 2023Steven Deitelzweig, MD, system chairman of hospital medicine at Ochsner Clinical School, professor of medicine at the University of Queensland, discusses key findings from a recent study on the accuracy of atrial fibrillation detection devices.
Read More
Avidity Biosciences Gains FDA Orphan Drug Designation for Patients With DMD
October 9th 2023Sarah Boyce, president and CEO at Avidity Biosciences, discusses her leading role at the company, as well as antibody oligonucleotide conjugate drug, AOC 1044, currently in development for Duchenne muscular dystrophy (DMD) with mutations amenable to exon 44 skipping (DMD44).
Read More
Mike Koroscik Discusses Population Health Reimbursement Models and Increased Lung Cancer Screening
October 7th 2023Mike Koroscik, MBA, MHA, vice president of oncology, Allina Health and the Allina Health Cancer Institute, discusses the successes and challenges of a population health reimbursement model and gives advice for other health organizations considering a similar partnership within their practices.
Read More
Dr Afreen Idris Shariff on the Value of e-Consults for Endocrine Toxicities of ICIs
October 7th 2023Afreen Idris Shariff, MD, MBBS, director at Duke Endo-Oncology Program, Duke Endocrinology, Duke Cancer Institute, discusses how e-consults are addressing specific endocrine immune-related adverse events from immune checkpoint inhibitors (ICIs), reducing time to appointment, and lowering the need for hospitalization.
Read More